
Batch PM-2026 analytical certificate verified by High-Performance Liquid Chromatography.
📄 Preview & Download Official COA (PDF) →FOXO4-DRI Research Compound (F410)
"Premium grade FOXO4-DRI validation."
FOXO4-DRI is a cell-penetrating D-retro-inverso peptide modeled on the FOXO4 p53-binding domain, studied as a senolytic research compound in cellular senescence research. It was shown to disrupt the FOXO4-p53 interaction and selectively induce apoptosis of senescent cells, restoring tissue homeostasis in chemotoxicity and aging mouse models (Baar et al., Cell 2017, PMID 28340347). FOXO4-DRI research peptide is supplied lyophilized at ≥98% purity verified by HPLC, with identity confirmed by mass spectrometry and a batch-specific Certificate of Analysis (COA) included. Store lyophilized powder at −20 °C, protected from light and moisture. For laboratory research use only — not for human or animal consumption.